1.
Muto T, Walker CS, Agarwal P, Vick E, Sampson A, Choi K, Niederkorn M, Ishikawa C, Hueneman K, Varney M, Starczynowski DT. Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation. haematol [Internet]. 2023Oct.1 [cited 2024Apr.25];108(10):2715-29. Available from: https://haematologica.org/article/view/haematol.2022.282349